Next Article in Journal
Connexin46 Expression Enhances Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Characteristics of Human Breast Cancer MCF-7 Cells
Next Article in Special Issue
Long-Term Sex- and Genotype-Specific Effects of 56Fe Irradiation on Wild-Type and APPswe/PS1dE9 Transgenic Mice
Previous Article in Journal
Pleiotropic Outcomes of Glyphosate Exposure: From Organ Damage to Effects on Inflammation, Cancer, Reproduction and Development
Previous Article in Special Issue
Ionising Radiation Promotes Invasive Potential of Breast Cancer Cells: The Role of Exosomes in the Process
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Long-Term Effects of Ionizing Radiation on the Hippocampus: Linking Effects of the Sonic Hedgehog Pathway Activation with Radiation Response

by
Francesca Antonelli
1,*,
Arianna Casciati
1,
Montserrat Belles
2,
Noemi Serra
2,
Maria Victoria Linares-Vidal
2,
Carmela Marino
1,
Mariateresa Mancuso
1 and
Simonetta Pazzaglia
1,*
1
Division of Health Protection Technologies, Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA), 00123 Rome, Italy
2
Physiology Unit, School of Medicine, Rovira I Virgili University (URV), 43007 Reus, Spain
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(22), 12605; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212605
Submission received: 22 September 2021 / Revised: 4 November 2021 / Accepted: 17 November 2021 / Published: 22 November 2021
(This article belongs to the Special Issue Molecular Research in Radiobiology)

Abstract

:
Radiation therapy represents one of the primary treatment modalities for primary and metastatic brain tumors. Although recent advances in radiation techniques, that allow the delivery of higher radiation doses to the target volume, reduce the toxicity to normal tissues, long-term neurocognitive decline is still a detrimental factor significantly affecting quality of life, particularly in pediatric patients. This imposes the need for the development of prevention strategies. Based on recent evidence, showing that manipulation of the Shh pathway carries therapeutic potential for brain repair and functional recovery after injury, here we evaluate how radiation-induced hippocampal alterations are modulated by the constitutive activation of the Shh signaling pathway in Patched 1 heterozygous mice (Ptch1+/−). Our results show, for the first time, an overall protective effect of constitutive Shh pathway activation on hippocampal radiation injury. This activation, through modulation of the proneural gene network, leads to a long-term reduction of hippocampal deficits in the stem cell and new neuron compartments and to the mitigation of radio-induced astrogliosis, despite some behavioral alterations still being detected in Ptch1+/− mice. A better understanding of the pathogenic mechanisms responsible for the neural decline following irradiation is essential for identifying prevention measures to contain the harmful consequences of irradiation. Our data have important translational implications as they suggest a role for Shh pathway manipulation to provide the therapeutic possibility of improving brain repair and functional recovery after radio-induced injury.

1. Introduction

Radiation therapy has long been an indispensable tool in the treatment for primary and secondary brain tumors, providing long-term survival benefits for patients. In the United States alone, radiation therapy is used to treat more than 200,000 patients a year, thus representing one of the main treatments for brain cancer. While effectively eliminating cancer cells, irradiation also induces damage in the healthy tissues, leading to severe cognitive impairments in up to 90% of patients undergoing whole-brain radiation therapy [1,2,3,4]. The dentate gyrus (DG) of the hippocampus represents one of the main brain sites of adult neurogenesis. It has been proposed that radiation injury to the neural stem cell compartment of the hippocampus may be involved in the cognitive decline, as well as other hippocampus-related side effects such as emotional alterations, observed during the follow-up of treated patients, particularly children [5,6].
Neurogenesis is the process by which new neurons arise from neural stem and progenitor cells, mature, specialize and become integrated and functional within the neuronal network. Although originally believed to occur only during developmental stages, it was demonstrated to occur in adult birds [7], rodents [8,9], and even humans [10,11]. The subgranular zone (SGZ) of the hippocampus contains the neurogenic “niche”, a specific microenvironment permissive for neuronal development that comprises the precursor cells, their immediate progeny and immature neurons, immune cells such as microglia and macrophages, endothelia and the extracellular matrix. Neurogenesis in adults does not occur at a constant rate and is affected by endogenous and exogenous factors, including hormones [12], physical and psychosocial stress [13], physical activity [14], diet [15], enriched environments [14] and age [16].
Impairment of neurogenesis in the hippocampus following whole-brain irradiation is now referred to as one of the most important mechanisms of radiation-induced cognitive dysfunction [17,18,19,20]. The critical role of the hippocampus in the pathogenesis of radiation-induced neurocognitive effects is also underlined by the observation that hippocampal avoidance seems to reduce the short-term memory decline in adults receiving whole-brain radiation therapy [21].
The Sonic hedgehog (Shh) signaling pathway is crucial for normal embryonic growth, development and organogenesis of almost all the organs in mammals, as well as in regeneration and homeostasis [22]. The Shh pathway consists mainly of SHH protein, the transmembrane receptor Patched (PTCH1), Smoothened (SMO), and the downstream zinc finger protein (GLI1) transcription factor. In the presence of SHH, PTCH1 relieves its suppression on SMO to activate the downstream transcription factor GLI1 and several downstream pathways.
Shh signaling has a pivotal role in the formation of neural germinal niches located in the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone of the hippocampal DG, and in nervous system cell type specification [23,24]. Direct proofs of its involvement in establishing neurogenic niches come from mouse studies in which Shh or Smo were ablated, causing several brain abnormalities including a reduced number of progenitors in the subventricular zone and subgranular zone [25]. Moreover, genetic ablation of the primary cilium, essential for Shh signaling, results in decreased Shh target gene expression and a phenotype similar to that of Smo-deficient mice [26,27]. In contrast, the constitutive expression of Smo (SmoM2-YFP) results in a marked expansion of the DG [27].
SHH has also been implicated in a wide array of events contributing to the maintenance of the adult central nervous system (CNS). We have recently shown that Shh signaling deregulation in mice with germline inactivation of one copy of the Ptch1 gene (Ptch1+/−) [28], besides DG patterning defects detectable as elongation and thinning of the blades, also causes deregulation at multiple steps during neurogenesis. In the DG of Ptch1+/− adult mice, this is detectable as a reduction of quiescent stem cells and newborn neurons and an accumulation of proliferating intermediate progenitors, indicative of defects in the dynamic transition among neural stages [29].
The deregulation of the Shh signaling pathway is important in brain tumor formation, regulation of cancer stem cell proliferation and in the control of tumor invasiveness [30,31,32]. More recently its role in many neurological and mood disorders, such as autism, depression, Parkinson’s disease, Huntington disease, epilepsy, diabetic neuropathy, demyelinating disease, locomotor deficit, cognitive dysfunction, ischemic and traumatic brain injury, has become clear [33,34]. Many evidences have also demonstrated the role of the Shh signaling pathway in CNS repair and regeneration after brain injury. Neuroprotective effects of the Shh signaling pathway in ischemic stroke, in the setting of complex neonatal cerebellar injury and in demyelinated lesions have been reported in recent studies [35,36,37], suggesting important therapeutic possibilities for the modulation of this pathway after brain injury.
In this study we investigated the in vivo long-term consequences of Shh signaling pathway activation on radio-induced effects in the hippocampus to seek for evidence of protection against radiation injury. Interestingly, our results show that constitutive activation of the Shh pathway in Ptch1+/− mice mitigates radiation-induced astrogliosis and deficits of neurogenesis, by preserving radiosensitive populations of neural stem and progenitor cells as well as newborn neurons in the SGZ of the DG from detrimental radiation effects. Elucidation of the mechanisms controlled by Shh signaling in the DG in response to radiation may lead to a better understanding of the etiology and treatment of brain radiation injury.

2. Results

2.1. Constitutive Activation of the Shh Signaling Pathway Mitigates Radiation-Induced Inhibition of Neurogenesis in the Hippocampus

In a previous work we have shown that constitutive Shh pathway activation induces alterations in the dynamic transition among neural stages, accumulating proliferating intermediate progenitors and newborn neurons in the DG of Ptch1+/− mice [29]. We therefore investigated the possible effects of Shh pathway activation on the mitigation of radiation-induced deficits in hippocampal neurogenesis, comparing the DG neurogenesis-rate in irradiated wild type (WT) and Ptch1+/− mice. To address this, we have examined the radiation-induced modifications in the cellular composition of the subgranular zone of the DG according to criteria based on morphological cellular features and labelling of stage-specific adult neurogenesis markers by immunohistochemical analyses.
As shown in Figure 1A, slowly dividing/quiescent radial glia-like cells (RGLs, type 1 cells), are featured with a single radial process that extends through the granular cell layer of the DG, and express GFAP. RGLs give rise to transit amplifying neural stem cells (TAPs) that are small round cells, expressing a sex determining region Y (SRY) box 2 (SOX2), that enlarge the pool of neurogenic cells (type 2a). The first indications of neuronal lineage choice appear at the level of type 2a cells and involve the suppression of Sox2 expression, critical for the transition from stem/progenitor cells to newborn neurons labelled by DCX (type 2b cells). Subsequently, newborn neurons progress into mature granule neurons that finally integrate in the existing neuronal circuit.
A comparison of stage-specific cellular markers in WT mice irradiated at P10 with 5 Gy of X-rays vs. unirradiated WT mice, indicates perturbations of adult hippocampal neurogenesis at 2 months after irradiation, detectable as a significant depletion of type1 RGL cells (−29% in GFAP+, p = 0.0097; Figure 1B), type 2a cells (−41% in SOX2+, p = 0.0002; Figure 1C), newly generated type 2b neurons (−32% in DCX+, p = 0.0139; Figure 1D) and the mature neuron density (−37% in NeuN, p < 0.0001; Figure 1E). Nearly all the depletions of irradiated WT mice were also detected in irradiated Ptch1+/− mice (−51% in GFAP, p < 0.0001; −43% in SOX2, p < 0.0001; −20% in NeuN, p = 0.0212) with the exception of newborn neurons labelled by DCX that were unchanged compared to the control (Figure 1B–E).
At 8 months after exposure, in WT mice we still observed the significant depletion of almost all the cellular compartments impaired at 2 months post-irradiation, including GFAP+ radial stem cells, SOX2+ neural progenitors and DCX+ newborn neurons (−45% in GFAP, p = 0.0206; −29% in SOX2, p = 0.0115; and −80% in DCX, p < 0.0001), except mature neurons labelled by NeuN that were back to basal levels (Figure 1B–E). These data indicated the long-term consequences of radiation injury on neurogenesis in WT mice, involving quiescent, dividing and differentiating neuronal populations. Notably, in marked contrast, the hippocampi of irradiated Ptch1+/− mice showed a complete recovery of all the stage-specific populations at 8 months post-irradiation, returning to the basal levels of the age-matched unirradiated Ptch1+/− mice, indicating that neurogenesis was completely restored.
Importantly, our data indicate that the constitutive activation of the Shh pathway mitigates the long-term consequences of irradiation on hippocampal neurogenesis, protecting both staminal and differentiated neuronal populations of the DG from the detrimental radiation effects that in WT, but not Ptch1+/− mice, were still detectable as a robust depletion at 8 months post-irradiation.

2.2. Constitutive Shh Pathway Activation Protects the Hippocampus from Radiation-Induced Astrogliosis

Astrocytes represent a cell population with distinctive morphological and functional characteristics and with a regulatory role in brain functions including neurogenesis and synaptogenesis, blood–brain barrier permeability and extracellular homeostasis, that undergo complex region-specific and age-dependent remodeling [27].
In this work GFAP, a well-established astrocyte marker, was used to follow the hippocampal astrocyte population in ML over time (Figure 2) [38]. In unirradiated brain labelled with anti-GFAP antibody, we observed a progressive decline in the astrocyte number between 2 and 8 months of age in hippocampi from both WT (−38%, p = 0.0012) and Ptch1+/− (−49%, p = 0.0007) mice, irrespective of the genotype. In agreement with our previously published results [29], we show here that Ptch1+/− mice consistently show a lower number of astrocytes compared to WT mice, both at 2 (−16%, p = 0.095) and 8 months (−31%, p = 0.0007), suggesting a role for the Shh pathway in the control of the astrocyte number. Astrocytes respond to various forms of CNS insults, including ionizing radiation, through a process called reactive astrogliosis, which has become a pathological hallmark of CNS structural lesions [39]. Accordingly, we show that while irradiation initially induces a depletion of astrocytes at 2 months post-irradiation in both genotypes compared to the unirradiated control (−28%, p = 0.0063 for WT; −24%, p = 0.0161 for Ptch1+/−), the number of astrocytes tends to increase with time at 8 months post-irradiation. However, while in WT mice we detected a significant increase of 24% in the number of astrocytes at 8 months post-irradiation, compared with 2 months (p = 0.021), in Ptch1+/− mice the small increase of 6% (p = 0.22) was not significant. Moreover, at 8 months post-irradiation WT mice showed a significantly higher number of astrocytes compared to age-matched irradiated Ptch1+/− mice (+31%, p = 0.0013; Figure 2).
Taken together our results indicate that constitutive Shh pathway activation effectively prevents the progressive radiation-induced astrogliosis, that was is in fact only observed in WT but not in Ptch1+/− mice, suggesting a role for Shh signaling in the regulation of the astrocyte population following injury.

2.3. Long-Term Effect of Constitutive Shh Pathway Activation on the Expression of Neurogenesis-Related Genes after Irradiation

Transcriptional control of adult neurogenesis represents the backbone of neuronal development. To investigate the molecular mechanisms of radiation-induced neurogenesis deficits and how the activation of the Shh pathway restrains this impairment, we evaluated the expression of neurogenesis-related genes in the irradiated hippocampi of WT and Ptch1+/− mice. We analyzed and compared RNA expression profiles of 84 genes with established roles in neurogenesis, at 8 months post-irradiation, when the protective effect of Shh pathway activation on radiation-dependent neurogenesis impairment was prominent. To address this, RNA extracted from the micro-dissected DG from unirradiated and 5 Gy irradiated Ptch1+/− and WT mice brains, was analyzed through a pathway-based PCR expression array approach. Our analysis showed that about 26% (22/84) and 33% (28/84) of the genes were still significantly deregulated (fold-regulation > 2; p ≤ 0.05) in irradiated compared to unexposed WT and Ptch1+/− mice, respectively. Most of the deregulated genes (15/22 in WT mice and 15/28 in Ptch1+/− mice) were common between irradiated WT and Ptch1+/− mice (Figure 3). It is interesting to note that by grouping the deregulated genes into functional categories (Table 1), most of the common deregulated genes fall in the “Synaptic functions” (7/15) and “Cell differentiation” (6/15) groups. This holds true for the exclusively deregulated genes in irradiated Ptch1+/− mice, also mainly belonging to the “Synaptic functions” (6/13) and “Cell differentiation” (3/13) groups. Some of the other exclusive genes for Ptch1+/− mice fall in the functional group of “Growth factors” (3/13) and “Cell Adhesion/Neural Migration” (3/13). Notably, three of the seven genes exclusively deregulated in irradiated WT mice, belong to the category of “Apoptosis”, representing the most numerous cluster in the exclusive genes for WT mice.

2.4. Effect of Constitutive Shh Pathway Activation on Radiation-Induced Changes in Mouse Behaviour

The hippocampus is an area of the brain with functions that are commonly linked with memory or dementia when dysfunctional. However, data suggest that it may also yield important clues about a range of mental health illnesses including addiction, anxiety and depression [40].
To evaluate whether Shh activation modifies the mouse behavioral response to irradiation, we compared the behavior of WT and Ptch1+/− mice 8 months post-irradiation through Open Field (OF) and Elevated Plus-Maze (EPM) tests. Firstly, our results showed an increase in exploration behaviors and locomotive functions, together with a decrease of anxiety-linked behaviors in unirradiated Ptch1+/− mice compared to WT controls when both Open Field (Figure 4A–C) or Elevated Plus-Maze tests (Figure 4D–G) were used. It is interesting to note that 8 months after irradiation, the behavior of Ptch1+/− mice showed an inversion, displaying an increased level of anxiety and decreased activity with respect to their unirradiated controls. In particular, results from the Open Field test showed a significant decrease in the number of rearings in Ptch1+/− mice 8 months after irradiation (Figure 4A). Moreover, compared to the unirradiated control, both the irradiated WT and Ptch1+/− mice showed a significant decrease in the total distance travelled (Figure 4B–C). Rearing is considered a useful marker of environmental novelty and can facilitate learning about the spatial environment. A decrease in exploration in a novel environment often means that ambulation and rearing are positively correlated [41]. The decrease observed in these parameters suggests an increase in anxiety-like behaviors, also confirmed by data obtained from the Elevated Plus-Maze test. In this test the irradiated Ptch1+/− mice showed a significant decrease in activity (total distance travelled and number of head dips, Figure 4D,G) and increased anxiety characterized by open arm avoidance (time and number of entries into the open arms, Figure 4D,F) compared to Ptch1+/− unirradiated mice.
Taken together, our data for the Open Field and Elevated Plus-Maze tests show a modulation of cognitive functions by the constitutive activation of the Shh pathway which is manifested as a decrease in locomotion and increase in anxiety levels.

3. Discussion

The brain undergoes ionizing radiation exposure in many clinical situations, particularly during radiotherapy for malignant brain tumors. Radiotherapy-related neurocognitive defects are prevalent in children, where they represent a major detrimental side effect of life-saving procedures [42,43] and correlate with the age at treatment, a younger age being associated with more severe neurocognitive deficiencies.
Accumulating evidence in animal models suggest that radiation-induced cognitive decline involves damage in multiple neural cell types, causing structural and functional alterations in the brain-blood barrier and in glial cell populations, reducing neurogenesis in the hippocampus, altering neuronal function, and increasing neuroinflammation [18,19,44,45].
Experimental animal models may shed light on the factors influencing the brain radiation response. In agreement with many published reports, WT mice displayed a progressive impairment of neurogenesis with a significant suppression of all the stem cell populations in the subgranular zone of the DG, and a reduction of new neurons at 2 months post-irradiation. These deficits worsened at 8 months post-irradiation, indicating that neurogenesis is progressively impaired in WT mice in the long term after irradiation with 5 Gy of X-rays. Of note, in WT mice this impairment was associated with exclusive upregulation of genes involved in the injury response such as adora2A (A2AR) and ep300. ep300 knockdown has been shown to inhibit apoptosis by disrupting the p53-mediated response to DNA damage [46,47], and A2AR plays an important role in radiation-induced skin injury, that benefits from its blockade. Moreover, inhibition of A2AR following brain injury is reported to protect oligodendrocytes against apoptosis and to enhance proliferation of their precursors in white matter [48]. Therefore, given the role of these two genes in apoptosis and the protection conferred by their knockdown it is conceivable that their long-term activation might be involved in the deficits of hippocampal neurogenesis observed in WT mice. In addition, Alk and Cxcl1 genes are exclusively downregulated in WT mice and it is noteworthy to mention that loss of function of both these genes is associated with reduced neurogenesis and alteration of behavioral measures, such as activity and anxiety levels [49,50,51], providing a further link between our molecular and phenotypic data in WT mice.
SHH is a key morphogen in the normal development of the CNS of vertebrates, such as the neural tube and brain, which is involved in the control of pattern formation, cell-fate-specification and maintenance of the proliferation, survival and differentiation of neurons in the CNS. In addition to acting as a mitogen for cells with stem-cell-like properties, SHH also promotes the axonal growth of young neurons soon after they are generated from progenitor cells [52,53]. Deregulation of the Shh signal pathway leads to the occurrence of a wide range of neurological diseases, including autism, depression, dementia, stroke, Parkinson’s disease, Huntington’s disease, motor disorders, epilepsy, demyelinating disease, neuropathy and brain tumors [33]. Recently, Shh deregulation has emerged as an important modulator of adult hippocampal neurogenesis, oxidation, inflammation, and autophagy [54]. We have previously shown that constitutive activation of the Shh pathway in Ptch1 heterozygous mice leads to morphological, cellular and molecular alterations in the DG, including elongation and reduced width of the DG, as well as deregulations at multiple steps during lineage progression from neural stem cells to neurons [29].
Several recent studies reported the potential neuroprotective therapeutic effects of Shh pathway manipulation in neurodegenerative disorders, cerebral ischemia and other pathologies [55,56,57]. In addition, it was shown that transient activation of the Shh pathway after irradiation rescued salivary gland function by preserving salivary stem/progenitor cells and parasympathetic innervation [58]. However, given that the potential of Shh pathway manipulation in the recovery of radiation injury is still unexplored, we here investigated the in vivo consequences of constitutive activation of the Shh pathway on the hippocampal radiation response. At 2 months post-irradiation the effect of exposure to 5 Gy of X-rays at P10 was milder in Ptch1+/− mice compared to WT mice, as they were protected from a deficit in the production of newborn neurons. Moreover, in the Ptch1+/− mice the deficits from irradiation of all the cell populations in the subgranular zone were completely recovered after 8 months. Therefore, our results show, for the first time, that the constitutive activation of the Shh pathway in Ptch1+/− mice robustly mitigates the radiation-induced inhibition of neurogenesis, by preserving radiosensitive populations of neural stem cells and progenitors, as well as newborn neurons in the DG. Notably, these results suggest an interesting potential role for Shh pathway manipulation among the strategies aimed at reducing radio-induced breakdown in the production of new neurons. Accordingly, our molecular analysis shows that irradiated Ptch1+/− mice overexpress several proneural genes, suggesting that combinatorial interactions between transcription factors upon constitutive activation of the Shh pathway, may establish a positive regulatory loop overcoming radiation-induced impairment of neurogenesis. The fibroblast growth factor (Fgf2) gene is an SHH-responding proneural gene able to restore hippocampal functions in a model of Alzheimer’s disease, partly as a result of enhanced neurogenesis [59,60]. Moreover Ptch1+/− mice overexpress Nrg1, a proneural gene able to increase hippocampal proliferation and neurogenesis within the hippocampus when peripherally administered to young adult mice [61]. Nrg1 overexpression can significantly attenuate neuronal death induced by oxygen-glucose deprivation in primary hippocampal neurons [62] and reduce ROS levels, increasing cell viability [63].
In general, our molecular analysis revealed a higher number of deregulated genes in Ptch1+/− compared to WT mice with respect to their matched unirradiated controls. These include genes involved in cell differentiation (Nrg1, Pafah1b1, Pax5, Ptn), synaptic functions (Chrm2, Fgf2, Pafah1b1, S100b, Apbb1, ApoE) and also transcription factors involved in the regulation of neurogenesis (Ptn, Flna). Many of these deregulated genes have implications in cognition, such as Nrg1, the overexpression of which, in addition to selectively increasing proliferation and overall neurogenesis, causes behavioral alterations [61,64], or Chrm2, which has been implicated in higher cognitive processing [65]. Pafah1b1 is the gene encoding the protein LIS1, involved in many aspects of neurogenesis, including cell differentiation, synaptic function regulation and neural migration, as well as being associated with lissencephaly, a neuronal migration disorder affecting the cerebral, hippocampal and cerebellar cortices [66,67]. Therefore, all these genes might be potential crucial mediators of the SHH-related regulatory molecular mechanisms providing neuroprotective and anti-inflammatory effects to the stress response in the adult hippocampus.
Experimental evidence shows that Ptch zebrafish mutants with constitutive activation of Shh signaling overexpress the Disrupted-In-Schizophrenia 1 gene (Disc1), suggesting that Disc1 functions downstream of SHH in the zebrafish CNS [68]. Notably, three of the genes we found deregulated in the irradiated Ptch1+/− hippocampi (Sox2, Pax5, and Dll1), were shown to be mediators of the Disc1-driven effects when Disc1 was overexpressed or silenced embryonically in mouse hippocampal neural stem precursor cells in vitro. Instead, in irradiated WT mice only Sox2 was downregulated, allowing us to speculate that the mitigation of radiation-induced effects observed in Ptch1+/− mice might be dependent on the molecular interactions between the Shh signaling pathway and Disc1, converging on the modulation of Pax5, Sox2 and Dll1.
Our findings also indicated important differences in the hippocampal astrocyte cell population between Ptch1+/− and WT mice, with a lower number of astrocytes in Ptch1+/− mice, suggesting that constitutive activation of the Shh pathway influences astrocyte homeostasis in the healthy brain. The network of astrocytes constitutes about 50% of the entire glial cell population, with diverse functions, including synaptic transmission modulation and secretion of growth factors [69,70]. In response to CNS injury, astrocytes become activated and respond by hypertrophy of their cellular processes and an increased production of the intermediate glial fibrillary acidic protein (GFAP) [71,72]. These permanent and irreversible modifications, known as reactive astrogliosis, have been described after brain exposure to ionizing radiation [73,74] and can persist from weeks to months to years after injury. Astrogliosis can occur following a single dose [75] or fractionated doses of radiation [76]. Concordantly, our data show that, following an initial depletion, irradiation induces a significant long-term increase of astrocytes in the hippocampus of WT mice. Instead, this was not observed in Ptch1+/− mice, indicating that activation of the Shh signaling pathway also protects from radiation-induced active astrogliosis. This was in line with recent findings showing that Shh signaling is active in astrocytes, mitigates inflammation under pathological conditions, and may provide a neuroprotective benefit to the restoration of tissue homeostasis following injury by reducing the permeability of the blood–brain barrier and limiting the extravasation of blood-derived inflammatory molecules into the CNS [77,78]. Moreover, growing evidence indicates that astrocytes participate not only in synaptic and neural circuit functions but also in various behaviors of an organism [79,80].
Noteworthily, astrocytes have a central role in the regulation of adult neurogenesis and changes in molecules produced by astrocytes have been shown to affect either positively or negatively different steps of adult neurogenesis. Pathological conditions, such as inflammation, lead to NSC dysfunction, altering the neuron-astrocyte production rate in favor of astrocytes [81,82], highlighting the importance of a tight control of the stem cell fate. Fgf2, exclusively upregulated in irradiated Ptch1+/− mice, is mainly produced by astrocytes and it is known to act as a proliferation inducing factor of NSCs [83,84]. Moreover, the FGF2/FGF receptor 1 pathway has been reported to inhibit astrocyte-mediated neuroinflammation in the hippocampus in vitro and in vivo after infrasound exposure [85,86]. Therefore, Fgf2 upregulation may provide a relevant molecular link between Shh hyperactivation and protection of the hippocampus from both radiation-induced neurogenesis impairment and astrogliosis. Fgf2, is also known as an extracellular inducer of the orphan nuclear hormone receptor COUP-TFII (chicken ovalbumin upstream promoter transcription factors II) [87]. COUP-TFII is a downstream target of Shh in P19 mouse cells [88]. Furthermore, Shh pathway activation in COUP-TFII mutant cells accounts for the imbalance of excitatory/inhibitory neuron differentiation in the primary somatosensory cortex, leading to the behavioral deficits of neurodevelopmental disorders, including autism spectrum disorders [89]. Therefore, since COUP-TFs are known to control the neuron-astroglia cell fate decision and are key modulators of neuroinflammation in the adult hippocampus [90,91], it is possible to hypothesize that Shh constitutive activation may contribute to mitigate the detrimental radiation effects in the hippocampus of Ptch1+/− mice through an Fgf2-mediated modulation of COUP-TFs receptors, although further studies are needed to prove it.
Ptch1 heterozygosity it is known to alter cognitive behaviors in mice, including reducing motor learning ability and performance on a spatial memory task, therefore linking dysregulation of the Shh signaling pathway with hyperactivity and altered social behaviors [29,92]. Very recently Ptch1+/− female mice were shown to have an increased activity compared to WT mice by traveling greater distances in both open-field and partner preference tasks [93]. Social behavior was also reported to be modified sex-specifically in Ptch1+/− females that interacted more with both novel and familiar animals in the partner preference task compared to WT controls of the same sex [88]. In agreement with these published data and with our previous indications that Shh-dependent neuroanatomical brain changes, including DG elongation, may alter social behavior in Ptch1+/− mice [29], we here show an increase in the exploration behaviors and locomotive functions in unirradiated Ptch1+/− mice compared to WT controls, even though our experimental groups included mice of both sexes and not only females. However, it is interesting to note that 8 months after irradiation, the behavior of Ptch1+/− mice showed an inversion, displaying an increased level of anxiety and decreased activity with respect to their unirradiated controls. This was not observed in WT mice, where only a decrease in the overall activity (Open Field test) was detected. Although, despite full recovery of the neurogenesis deficit, the persistence of behavioral disturbances in Ptch1+/− mice at 8 months post-irradiation was somewhat unexpected, it should be considered that (i) behavioral abnormalities were also observed in unirradiated Ptch1+/− mice, (ii) that irradiation was not targeted to the hippocampus but delivered to the whole-body, and (iii) it was carried out at P10, the most vulnerable period for the brain, in which the slightest disturbance may affect the development and result in neurotoxicity in adult mice [94]. Therefore, subtle and complex interactions between the constitutive Shh pathway activation and radiation injuries, also extending to other brain regions besides the hippocampus, may account for the alteration in anxiety and locomotion activities in irradiated Ptch1+/− mice. However, further evaluations with a wider range of behavioral tests may help to highlight behavioral dysfunction, demonstrating the role of Shh in functional recovery after radio-induced injury.
Several studies reveal that manipulation of the Shh pathway carries therapeutic potential in neurodegenerative disorders and cerebral ischemia [56,57,95,96,97,98,99]. After stroke the Shh pathway is upregulated in multiple cell types and post-stroke treatment with an SHH agonist in a distal middle cerebral artery occlusion model leads to functional improvement in the subacute phase after stroke [100]. Treatment with an Shh pathway agonist in stroke mice resulted in enhanced functional recovery in locomotor and cognitive functions, as well as in neurogenesis by increasing the survival of newly born cells derived from both subventricular zone and subgranular zone neural stem cells, total DCX+ neuroblast cells, and neurons (NeuN+/YFP+) in the ischemic brain [101]. It was also reported that treatment with a different Shh pathway agonist (Purmorphamine) administered at an early post-stroke stage (6 h) leads to decreased neuronal damage, BBB integrity and reduced reactive astrogliosis [102]. Finally, anatomical and behavioral deficits in a mouse model of Down syndrome have also reportedly been corrected by a single injection with an Shh signaling pathway agonist (SAG) at birth, suggesting that temporary Shh pathway activation could lead to long-term modulation of brain development and functions [103]. On the other hand, a massive shortfall in PTCH1 and GLI1 was observed in the hippocampus of aged Alzheimer disease transgenic mice that would compromise the ability of genesis in both NSC and glial precursor cells [104]. According to the above evidence, our findings support a role for Shh pathway manipulation to provide the therapeutic possibility of improving brain repair and functional recovery after radiation injury. Future experiments in which irradiated WT mice are treated with an Shh pathway agonist are required to establish a role for Shh pathway manipulation against radiation-induced detrimental consequences in the brain.

4. Materials and Methods

4.1. Animals and Irradiation

Female and male mice lacking one Ptch1 allele (Ptch1neo6−7/+, named Ptch1+/− throughout the text), generated through the disruption of exons 6 and 7 in 129/Sv embryonic stem cells and maintained on a CD1 background, were bred and genotyped as described in [28]. Animals were housed under conventional conditions with food and water available ad libitum and a 12-h light cycle. All the experiments were carried out in accordance to the Directive 2010/63/EU for animal experiments. Experimental protocols were reviewed by the Institutional Animal Care and Use Committee, and permission was issued by the “Ministero della Salute” (Approval number is 365/2015-PR).
X-ray irradiation was performed using a Gilardoni CHF 320G X-ray generator (Gilardoni S.p.A.; Mandello del Lario, Lecco, Italy) operated at 250 kVp, 15 mA, with filters of 2.0 mm of Al and 0.5 mm of Cu. Ptch1+/− mice and WT littermates of both sexes were whole-body irradiated with 5 Gy of X-rays 10 days after birth (P10) during the peak of the brain growth spurt, a developmental phase characterized by a marked growth in brain size, and recognized as a critical sensitive period for toxic insults [105]. This was performed without anesthesia to avoid further stress in addition to irradiation (Figure S1A). Additional groups were left untreated as controls. Acute mortality before mice weaning was less than 12% of the P10-irradiated mice (Figure S1B). At the end of the experiments, animals were sacrificed by cervical dislocation.

4.2. Immunohistochemistry

Brains from unirradiated and irradiated mice (n ≥ 4) were collected at different time points, fixed in 10% buffered formalin and embedded in paraffin wax according to standard techniques. Fixed brain sections were immunostained as described in [106] using the following primary antibodies diluted as indicated by the manufacturer: GFAP (Z0334—Dako, Jena, Germany, 1:500), SOX2 (ab97959—Abcam, Cambridge, UK, 1:500), DCX (18723—Abcam, Cambridge, UK, 1:2000), NeuN (MAB377—Millipore, Darmstadt Germany) and IBA1 (019-19741, Wako, Richmond, VA, USA, 1:500). To analyze adult neurogenesis, the brain of each mouse was cut sagittally to the midline and sections were collected starting at around 300 µm from the midline. To standardize the counting area, cell quantification was performed on three nonoverlapping serially collected sections per mouse, one from each hemisphere, representing the rostral/mid-hippocampus. Images for quantification were taken using the imaging software NIS-Elements BR 4.00.05 (Nikon Instruments Europe B.V., Amesterdam, The Netherlands). All experiments were blind analyzed by an independent researcher to the injury. The number of positive cells in each section of the subgranular zone was expressed per mm of the subgranular zone length. NSCs were counted based on criteria including subgranular zone localization, positive labelling and morphology. Immunohistochemical analysis for NeuN was carried out in a rectangular field of 2000 µm2 in the supra- and infrapyramidal blade and in the crest area of the DG. Quantitative analysis of astroglial (GFAP+) cells were performed in the molecular layer (ML) of the hippocampus and expressed as positive cells/mm2. Representative immunostaining images are reported in the Supplementary Material for each condition (Figures S2 and S3). All data were evaluated with GraphPad Prism 6 statistical software (GraphPad Software Inc., San Diego, CA, USA). Statistical significance between groups for most variables was determined using a Student two-tailed t-test with or without Welch’s correction. p-values < 0.05 were considered to be statistically significant.

4.3. RT2 Profiler PCR Array

Brains were collected at 8 months after irradiation and stored in RNAlater solution (1018087—Qiagen, Hilden, Germany) over-night at 4 °C. Then, DGs were manually dissected under a stereomicroscope according to the procedure illustrated in the video at https://0-www-jove-com.brum.beds.ac.uk/video/1543/dissection-ofhippocampal-dentate-gyrus-from-adult-mouse (accessed on 17 November 2009) [107] and stored at −80 °C in RNAlater until RNA extraction. To quantify gene expression of 84 genes involved in the neurogenic process we used the RT2 Profiler Mouse Neurogenesis PCR Array (PAMM-404Z, SABiosciences, Qiagen, Hilden, Germany). Total RNA (0.5 µg) from the DGs of irradiated and control mice (n = 4), was used on a StepOnePlus™ Real-Time PCR System (Applied Biosystems, Life Technologies, Monza, Italy) according to the manufacturer’s instructions. Only Ct values of <35 were included in the calculations. The relative expression of each mRNA was normalized using the equation 2−∆∆Ct. For each genotype, three replicates were carried out and a gene was considered to have a significantly altered expression only if displaying a fold-regulation higher/less than 2, with a p value ≤ 0.05. Gene expression was related to the mean expression of all five housekeeping genes included in the array.

4.4. Cognitive Tests

Behavioral analyses were carried out in control and irradiated Ptch1+/− (n = 15 at 0 Gy; n = 12 at 5 Gy) and WT mice (n = 18 at 0 Gy; n = 17 at 5 Gy) of mixed genders at 8 months after irradiation.
Open-Field (OF) Test: An Open Field test was used to assess the anxiety-like and activity levels of the animals. The open field consisted of a wooden square (47 cm × 47 cm) surrounded by a dark wall (40 cm). The area of the maze within 15 cm of the wall was considered as peripheral [108,109], while the rest was the central area. At the beginning of the test mice were placed in the center of the arena and allowed to move freely around the maze to explore the environment for 15 min. To remove olfactory cues from the previous animal, the apparatus was cleaned with 70% ethanol after each observation. The video tracking software Ethovision XT© 14 (Noldus Information Technologies, Wageningen, Netherlands), was used to measure the distance travelled over the maze. Additionally, the number of rearings (vertical standing of mice on hind legs) were registered. During the behavioral testing, indirect lighting was used and lighting levels maintained at ≈100 lux [110,111].
Elevated Plus Maze (EPM) Test: The Elevated Plus Maze test was used to assess anxiety-like levels in mice. The apparatus used has two closed arms (25 × 5 × 16 cm) across from each other and perpendicular to two open arms (25 × 5 × 0.5 cm), with a center platform (5 × 5 × 0.5 cm). In the open arms, a small wall (0.5 cm) is used to decrease the number of falls. The entire apparatus is 50 cm above the floor. Mice were transported to the testing room 30 min before the tests. At the start of the session each animal was placed in the central square and allowed to freely explore the environment for 5 min. To remove olfactory cues from the previous animal, the apparatus was cleaned with 70% ethanol after each observation. Performance was recorded by a video camera and data were analyzed with Ethovision XT© version 11.5 (Noldus Information Technologies) video tracking software to measure the time spent in open arms [112,113]. In addition, the number of head dips (downward movements of the head towards the floor) was registered.
Cognitive Statistical Analysis: Data were reported as the mean ± standard error of the mean (SEM). Homogeneity of variances were analyzed using Levene’s test. If variances were homogeneous, ANOVA was used followed by the Tukey post hoc test to evaluate all dose groups simultaneously. If the variances were not homogeneous, the Kruskal–Wallis test was used. Differences between groups were analyzed using the Mann–Whitney U-test. Moreover, the paired t-test was used to compare the two different time points tested. The ANOVA test and post hoc analyses adjusted by Bonferroni’s correction were used to analyze the progression for repeated measures of parameters recorded by the Ethovision XT© software (version 11.5). The level of statistical significance for all tests was established at p < 0.05. All data were analyzed by means of the statistical package GraphPad Prism 6 statistical software (GraphPad Software Inc., San Diego, CA, USA).

5. Conclusions

Originally discovered as a mitogen and crucial for CNS development including patterning and polarity, SHH is now appreciated for its various functions to cope with different types of stresses and multiple potential neuroprotective mechanisms. Of great translational interest, our data, by showing a long-term reduction of the hippocampal deficits in the stem and new neuron compartments and mitigation of astrogliosis induced by P10 irradiation in Ptch1+/− mice, demonstrated that constitutive activation of the Shh signaling pathway, by modulating the proneural gene network, protects the hippocampus from radiation damage (Figure 5). This finding has important implications given the prevalence of radiotherapy-related neurocognitive defects in children. However, unexpectedly, deficits in mood and locomotion could still be detected in irradiated Ptch1+/− mice, although other brain areas may contribute to these behavioral changes. Our results demonstrated an overall protective effect of constitutive Shh pathway activation on the hippocampal injury derived from perinatal radiation exposure. However, further investigations on the responses triggered by a transient Shh pathway activation to hippocampal recovery following cranial-irradiation, are needed to facilitate its potential clinical application, with particular attention to the establishment of an appropriate time window for intervention and the potential for CNS oncogenic effects.

Supplementary Materials

Author Contributions

Conceptualization, S.P. and F.A.; methodology, F.A, S.P., M.B., N.S., A.C. and M.V.L.-V.; software, F.A., M.B. and N.S.; validation, F.A., A.C. and M.V.L.-V.; investigation, S.P., F.A., A.C., M.B. and N.S.; resources, M.M. and C.M.; data curation, S.P. and F.A.; writing-original draft preparation, S.P. and F.A.; writing-review and editing S.P., F.A., A.C. and M.V.L.-V.; visualization, S.P., M.M., C.M. and M.V.L.-V.; supervision, S.P.; project administration, S.P., M.M. and C.M.; funding acquisition, C.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the TOP-IMPLART Project, funded by the Local Government of the Regione Lazio, developed by the collaboration between ENEA (Italian National Agency for new technologies, energy and sustainable economic development), ISS (Italian National Institute of Health) and IFO-IRE (National Cancer Institute in Rome). This publication reflects only the authors’ views. Responsibility for the information and views expressed therein lies entirely with the authors.

Institutional Review Board Statement

This study was conducted according to the European Community Council Directive 2010/63/EU, approved by the local Ethical Committee for Animal Experiments of the ENEA, and authorized by the Italian Ministry of Health (n° 539/2018-PR).

Informed Consent Statement

Not applicable.

Data Availability Statement

Other datasets analyzed during the study are available from the corresponding authors on reasonable request.

Acknowledgments

The present work was supported by the TOP-IMPLART project from Regione Lazio (Italy).

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

Ptch1Patched
DGDentate Gyrus
ShhSonic Hedgehog
SMOSmoothened
SVZSubventricular zone
SGZSubgranular zone
GCLGranular cell layer
WTWild Type
CNSCentral nervous system
RGLsRadial glia-like cells
TAPsTransit amplifying neural stem cells
DCXDoublecortin
FCFold-changes
GFAPGlial fibrillary acidic protein
NSCNeural stem cells
SOX2Sex determining region Y (SRY) box 2
OFOpen field test
EPMElevated plus-maze test
NSPCNeural stem precursor cell
COUP-TFsChicken ovalbumin upstream promoter transcription factors

References

  1. Ahles, T.A.; Root, J.C.; Ryan, E.L. Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science. J. Clin. Oncol. 2012, 30, 3675–3686. [Google Scholar] [CrossRef]
  2. DeSantis, C.E.; Lin, C.C.; Mariotto, A.B.; Siegel, R.L.; Stein, K.D.; Kramer, J.L.; Alteri, R.; Robbins, A.S.; Jemal, A. Cancer treatment and survivorship statistics, 2014. CA A Cancer J. Clin. 2014, 64, 252–271. [Google Scholar] [CrossRef] [PubMed]
  3. Perry, A.; Schmidt, R.E. Cancer therapy-associated CNS neuropathology: An update and review of the literature. Acta Neuropathol. 2006, 111, 197–212. [Google Scholar] [CrossRef] [PubMed]
  4. Smart, D. Radiation Toxicity in the Central Nervous System: Mechanisms and Strategies for Injury Reduction. Semin. Radiat. Oncol. 2017, 27, 332–339. [Google Scholar] [CrossRef] [PubMed]
  5. Redmond, K.J.; Milano, M.T.; Kim, M.M.; Trifiletti, D.M.; Soltys, S.G.; Hattangadi-Gluth, J.A. Reducing Radiation-Induced Cognitive Toxicity: Sparing the Hippocampus and Beyond. Int. J. Radiat. Oncol. Biol. Phys. 2021, 109, 1131–1136. [Google Scholar] [CrossRef] [PubMed]
  6. Son, Y.; Yang, M.; Wang, H.; Moon, C. Hippocampal dysfunctions caused by cranial irradiation: A review of the experimental evidence. Brain Behav. Immun. 2015, 45, 287–296. [Google Scholar] [CrossRef]
  7. Goldman, S.A.; Nottebohm, F. Neuronal production, migration, and differentiation in a vocal control nucleus of the adult female canary brain. Proc. Natl. Acad. Sci. USA 1983, 80, 2390–2394. [Google Scholar] [CrossRef] [Green Version]
  8. Altman, J.; Das, G.D. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J. Comp. Neurol. 1965, 124, 319–335. [Google Scholar] [CrossRef]
  9. Van Praag, H.; Christie, B.R.; Sejnowski, T.J.; Gage, F.H. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. USA 1999, 96, 13427–13431. [Google Scholar] [CrossRef] [Green Version]
  10. Eriksson, P.S.; Perfilieva, E.; Bjork-Eriksson, T.; Alborn, A.-M.; Nordborg, C.; Peterson, D.A.; Gage, F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 1998, 4, 1313–1317. [Google Scholar] [CrossRef]
  11. Spalding, K.L.; Bergmann, O.; Alkass, K.; Bernard, S.; Salehpour, M.; Huttner, H.B.; Boström, E.; Westerlund, I.; Vial, C.; Buchholz, B.A.; et al. Dynamics of Hippocampal Neurogenesis in Adult Humans. Cell 2013, 153, 1219–1227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Tanapat, P.; Hastings, N.B.; Reeves, A.J.; Gould, E. Estrogen Stimulates a Transient Increase in the Number of New Neurons in the Dentate Gyrus of the Adult Female Rat. J. Neurosci. 1999, 19, 5792–5801. [Google Scholar] [CrossRef] [PubMed]
  13. Gould, E.; Tanapat, P.; Hastings, N.B.; Shors, T.J. Neurogenesis in adulthood: A possible role in learning. Trends Cogn. Sci. 1999, 3, 186–192. [Google Scholar] [CrossRef]
  14. Brown, J.; Cooper-Kuhn, C.M.; Kempermann, G.; van Praag, H.; Winkler, J.; Gage, F.H.; Kuhn, H.G. Enriched environment and physical activity stimulate hippocampal but not olfactory bulb neurogenesis. Eur. J. Neurosci. 2003, 17, 2042–2046. [Google Scholar] [CrossRef]
  15. Murphy, T.; Dias, G.P.; Thuret, S. Effects of Diet on Brain Plasticity in Animal and Human Studies: Mind the Gap. Neural Plast. 2014, 2014, 563160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Kuhn, H.-G.; Dickinson-Anson, H.; Gage, F.H. Neurogenesis in the dentate gyrus of the adult rat: Age-related decrease of neuronal progenitor proliferation. J. Neurosci. 1996, 16, 2027–2033. [Google Scholar] [CrossRef] [Green Version]
  17. Haldbo-Classen, L.; Amidi, A.; Lukacova, S.; Wu, L.M.; von Oettingen, G.; Lassen-Ramshad, Y.; Zachariae, R.; Kallehauge, J.F.; Høyer, M. Cognitive impairment following radiation to hippocampus and other brain structures in adults with primary brain tumours. Radiother. Oncol. 2020, 148, 1–7. [Google Scholar] [CrossRef] [PubMed]
  18. Makale, M.T.; McDonald, C.R.; Hattangadi-Gluth, J.A.; Kesari, S. Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours. Nat. Rev. Neurol. 2017, 13, 52–64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Pazzaglia, S.; Briganti, G.; Mancuso, M.; Saran, A. Neurocognitive Decline Following Radiotherapy: Mechanisms and Therapeutic Implications. Cancers 2020, 12, 146. [Google Scholar] [CrossRef] [Green Version]
  20. Pereira Dias, G.; Hollywood, R.; Bevilaqua, M.C.; da Luz, A.C.; Hindges, R.; Nardi, A.E.; Thuret, S. Consequences of cancer treatments on adult hippocampal neurogenesis: Implications for cognitive function and depressive symptoms. Neuro-Oncology 2014, 16, 476–492. [Google Scholar] [CrossRef] [Green Version]
  21. Gondi, V.; Tomé, W.; Mehta, M. Why avoid the hippocampus? A comprehensive review. Radiother. Oncol. 2010, 97, 370–376. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Carballo, G.B.; Honorato, J.R.; De Lopes, G.P.F.; Spohr, T. A highlight on Sonic hedgehog pathway. Cell Commun. Signal. 2018, 16, 11. [Google Scholar] [CrossRef] [PubMed]
  23. Ihrie, R.A.; Alvarez-Buylla, A. Cells in the astroglial lineage are neural stem cells. Cell Tissue Res. 2008, 331, 179–191. [Google Scholar] [CrossRef] [PubMed]
  24. Zhao, C.; Deng, W.; Gage, F.H. Mechanisms and Functional Implications of Adult Neurogenesis. Cell 2008, 132, 645–660. [Google Scholar] [CrossRef] [Green Version]
  25. Machold, R.; Hayashi, S.; Rutlin, M.; Muzumdar, M.D.; Nery, S.; Corbin, J.G.; Gritli-Linde, A.; Dellovade, T.; Porter, J.A.; Rubin, L.L.; et al. Sonic Hedgehog Is Required for Progenitor Cell Maintenance in Telencephalic Stem Cell Niches. Neuron 2003, 39, 937–950. [Google Scholar] [CrossRef] [Green Version]
  26. Breunig, J.J.; Sarkisian, M.R.; Arellano, J.I.; Morozov, Y.M.; Ayoub, A.E.; Sojitra, S.; Wang, B.; Flavell, R.A.; Rakic, P.; Town, T. Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. Proc. Natl. Acad. Sci. USA 2008, 105, 13127–13132. [Google Scholar] [CrossRef] [Green Version]
  27. Han, Y.-G.; Spassky, N.; Romaguera-Ros, M.; Garcia-Verdugo, J.M.; Aguilar, A.; Schneider-Maunoury, S.; Alvarez-Buylla, A. Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells. Nat. Neurosci. 2008, 11, 277–284. [Google Scholar] [CrossRef]
  28. Hahn, H.; Wojnowski, L.; Zimmer, A.M.; Hall, J.; Miller, G.; Zimmer, A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med. 1998, 4, 619–622. [Google Scholar] [CrossRef]
  29. Antonelli, F.; Casciati, A.; Tanori, M.; Tanno, B.; Linares, V.; Serra, N.; Belles, M.; Pannicelli, A.; Saran, A.; Pazzaglia, S. Alterations in Morphology and Adult Neurogenesis in the Dentate Gyrus of Patched1 Heterozygous Mice. Front. Mol. Neurosci. 2018, 11, 168. [Google Scholar] [CrossRef]
  30. Gajjar, A.J.; Robinson, G.W. Medulloblastoma—Translating discoveries from the bench to the bedside. Nat. Rev. Clin. Oncol. 2014, 11, 714–722. [Google Scholar] [CrossRef]
  31. Gupta, S.; Takebe, N.; Lorusso, P. Targeting the Hedgehog pathway in cancer. Ther. Adv. Med. Oncol. 2010, 2, 237–250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Laukkanen, M.O.; Castellone, M.D. Hijacking the Hedgehog Pathway in Cancer Therapy. Anti-Cancer Agents Med. Chem. 2016, 16, 309–317. [Google Scholar] [CrossRef] [PubMed]
  33. Patel, S.S.; Tomar, S.; Sharma, D.; Mahindroo, N.; Udayabanu, M. Targeting sonic hedgehog signaling in neurological disorders. Neurosci. Biobehav. Rev. 2017, 74, 76–97. [Google Scholar] [CrossRef]
  34. Toda, T.; Parylak, S.L.; Linker, S.B.; Gage, F.H. The role of adult hippocampal neurogenesis in brain health and disease. Mol. Psychiatry 2019, 24, 67–87. [Google Scholar] [CrossRef] [PubMed]
  35. Laouarem, Y.; Traiffort, E. Developmental and Repairing Production of Myelin: The Role of Hedgehog Signaling. Front. Cell. Neurosci. 2018, 12, 305. [Google Scholar] [CrossRef] [PubMed]
  36. Liu, L.; Zhao, B.; Xiong, X.; Xia, Z. The Neuroprotective Roles of Sonic Hedgehog Signaling Pathway in Ischemic Stroke. Neurochem. Res. 2018, 43, 2199–2211. [Google Scholar] [CrossRef] [PubMed]
  37. Nguyen, V.; Sabeur, K.; Maltepe, E.; Ameri, K.; Bayraktar, O.; Rowitch, D.H. Sonic Hedgehog Agonist Protects Against Complex Neonatal Cerebellar Injury. Cerebellum 2018, 17, 213–227. [Google Scholar] [CrossRef] [Green Version]
  38. Jinno, S. Regional and laminar differences in antigen profiles and spatial distributions of astrocytes in the mouse hippocampus, with reference to aging. Neuroscience 2011, 180, 41–52. [Google Scholar] [CrossRef]
  39. Sofroniew, M.V.; Vinters, H.V. Astrocytes: Biology and pathology. Acta Neuropathol. 2010, 119, 7–35. [Google Scholar] [CrossRef] [Green Version]
  40. Anand, K.S.; Dhikav, V. Hippocampus in health and disease: An overview. Ann. Indian Acad. Neurol. 2012, 15, 239–246. [Google Scholar] [CrossRef]
  41. Lever, C.; Burton, S.; O’Keefe, J. Rearing on Hind Legs, Environmental Novelty, and the Hippocampal Formation. Rev. Neurosci. 2006, 17, 111–133. [Google Scholar] [CrossRef]
  42. Askins, M.A.; Moore, B.D., 3rd. Preventing Neurocognitive Late Effects in Childhood Cancer Survivors. J. Child Neurol. 2008, 23, 1160–1171. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Cramer, C.K.; Cummings, T.L.; Andrews, R.N.; Strowd, R.; Rapp, S.R.; Shaw, E.G.; Chan, M.D.; Lesser, G.J. Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients. Curr. Treat. Options Oncol. 2019, 20, 42. [Google Scholar] [CrossRef] [PubMed]
  44. Constanzo, J.; Midavaine, E.; Fouquet, J.; Lepage, M.; Descoteaux, M.; Kirby, K.; Tremblay, L.; Masson-Cote, L.; Geha, S.; Longpre, J.M.; et al. Brain irradiation leads to persistent neuroinflammation and long-term neurocognitive dysfunction in a region-specific manner. Prog. Neuropsychopharmacol. Biol. Psychiatry 2020, 102, 109954. [Google Scholar] [CrossRef] [PubMed]
  45. Turnquist, C.; Harris, B.T.; Harris, C.C. Radiation-induced brain injury: Current concepts and therapeutic strategies targeting neuroinflammation. Neuro-Oncol. Adv. 2020, 2, vdaa057. [Google Scholar] [CrossRef] [PubMed]
  46. Iyer, N.G.; Chin, S.F.; Ozdag, H.; Daigo, Y.; Hu, D.E.; Cariati, M.; Brindle, K.; Aparicio, S.; Caldas, C. p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels. Proc. Natl. Acad. Sci. USA 2004, 101, 7386–7391. [Google Scholar] [CrossRef] [Green Version]
  47. Yuan, Z.M.; Huang, Y.; Ishiko, T.; Nakada, S.; Utsugisawa, T.; Shioya, H.; Utsugisawa, Y.; Yokoyama, K.; Weichselbaum, R.; Shi, Y.; et al. Role for p300 in Stabilization of p53 in the Response to DNA Damage. J. Biol. Chem. 1999, 274, 1883–1886. [Google Scholar] [CrossRef] [Green Version]
  48. Al-Griw, M.A.; Alghazeer, R.O.; Awayn, N.; Shamlan, G.; Eskandrani, A.A.; Alnajeebi, A.M.; Babteen, N.A.; Alansari, W.S. Selective adenosine A2A receptor inhibitor SCH58261 reduces oligodendrocyte loss upon brain injury in young rats. Saudi J. Biol. Sci. 2021, 28, 310–316. [Google Scholar] [CrossRef]
  49. Huang, F.; Lan, Y.; Qin, L.; Dong, H.; Shi, H.; Wu, H.; Zou, Q.; Hu, Z.; Wu, X. Astragaloside IV Promotes Adult Neurogenesis in Hippocampal Dentate Gyrus of Mouse through CXCL1/CXCR2 Signaling. Molecules 2018, 23, 2178. [Google Scholar] [CrossRef] [Green Version]
  50. Weiss, J.B.; Xue, C.; Benice, T.; Xue, L.; Morris, S.W.; Raber, J. Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase: Functions and genetic interactions in learning, memory and adult neurogenesis. Pharmacol. Biochem. Behav. 2012, 100, 566–574. [Google Scholar] [CrossRef]
  51. Zhao, X.; Rouhiainen, A.; Li, Z.; Guo, S.; Rauvala, H. Regulation of Neurogenesis in Mouse Brain by HMGB1. Cells 2020, 9, 1714. [Google Scholar] [CrossRef]
  52. Gong, Q.; Chen, H.; Farbman, A.I. Olfactory sensory axon growth and branching is influenced by sonic hedgehog. Dev. Dyn. 2009, 238, 1768–1776. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Parra, L.M.; Zou, Y. Sonic hedgehog induces response of commissural axons to Semaphorin repulsion during midline crossing. Nat. Neurosci. 2010, 13, 29–35. [Google Scholar] [CrossRef] [PubMed]
  54. Chen, S.-D.; Yang, J.-L.; Hwang, W.-C.; Yang, D.-I. Emerging Roles of Sonic Hedgehog in Adult Neurological Diseases: Neurogenesis and Beyond. Int. J. Mol. Sci. 2018, 19, 2423. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. De Stefano, I.; Tanno, B.; Giardullo, P.; Leonardi, S.; Pasquali, E.; Antonelli, F.; Tanori, M.; Casciati, A.; Pazzaglia, S.; Saran, A.; et al. The Patched 1 Tumor-Suppressor Gene Protects the Mouse Lens from Spontaneous and Radiation-Induced Cataract. Am. J. Pathol. 2015, 185, 85–95. [Google Scholar] [CrossRef]
  56. Madhavan, L.; Daley, B.F.; Davidson, B.L.; Boudreau, R.L.; Lipton, J.W.; Cole-Strauss, A.; Steece-Collier, K.; Collier, T.J. Sonic Hedgehog Controls the Phenotypic Fate and Therapeutic Efficacy of Grafted Neural Precursor Cells in a Model of Nigrostriatal Neurodegeneration. PLoS ONE 2015, 10, e0137136. [Google Scholar] [CrossRef]
  57. Zhang, Y.; Dong, W.; Guo, S.; Zhao, S.; He, S.; Zhang, L.; Tang, Y.; Wang, H. Lentivirus-mediated delivery of sonic hedgehog into the striatum stimulates neuroregeneration in a rat model of Parkinson disease. Neurol. Sci. 2014, 35, 1931–1940. [Google Scholar] [CrossRef]
  58. Hai, B.; Zhao, Q.; Qin, L.; Rangaraj, D.; Gutti, V.R.; Liu, F. Rescue Effects and Underlying Mechanisms of Intragland Shh Gene Delivery on Irradiation-Induced Hyposalivation. Hum. Gene Ther. 2016, 27, 390–399. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Kiyota, T.; Ingraham, K.L.; Jacobsen, M.T.; Xiong, H.; Ikezu, T. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer’s disease and has therapeutic implications for neurocognitive disorders. Proc. Natl. Acad. Sci. USA 2011, 108, E1339–E1348. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  60. Sousa, V.H.; Fishell, G. Sonic hedgehog functions through dynamic changes in temporal competence in the developing forebrain. Curr. Opin. Genet. Dev. 2010, 20, 391–399. [Google Scholar] [CrossRef] [Green Version]
  61. Mahar, I.; MacIsaac, A.; Kim, J.J.; Qiang, C.; Davoli, M.A.; Turecki, G.; Mechawar, N. Effects of neuregulin-1 administration on neurogenesis in the adult mouse hippocampus and characterization of immature neurons along the septotemporal axis. Sci. Rep. 2016, 6, 30467. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Yoo, J.Y.; Kim, H.B.; Yoo, S.Y.; Yoo, H.I.; Song, D.Y.; Baik, T.K.; Lee, J.H.; Woo, R.S. Neuregulin 1/ErbB4 signaling attenuates neuronal cell damage under oxygen-glucose deprivation in primary hippocampal neurons. Anat. Cell Biol. 2019, 52, 462–468. [Google Scholar] [CrossRef] [PubMed]
  63. Goldshmit, Y.; Erlich, S.; Pinkas-Kramarski, R. Neuregulin Rescues PC12-ErbB4 Cells from Cell Death Induced by H2O2. J. Biol. Chem. 2001, 276, 46379–46385. [Google Scholar] [CrossRef] [Green Version]
  64. Deakin, I.H.; Nissen, W.; Law, A.J.; Lane, T.; Kanso, R.; Schwab, M.H.; Nave, K.A.; Lamsa, K.P.; Paulsen, O.; Bannerman, D.M.; et al. Transgenic Overexpression of the Type I Isoform of Neuregulin 1 Affects Working Memory and Hippocampal Oscillations but not Long-term Potentiation. Cereb. Cortex 2012, 22, 1520–1529. [Google Scholar] [CrossRef] [Green Version]
  65. Gosso, F.M.; De Geus, E.J.; Polderman, T.J.; Boomsma, D.I.; Posthuma, D.; Heutink, P. Exploring the functional role of the CHRM2 gene in human cognition: Results from a dense genotyping and brain expression study. BMC Med. Genet. 2007, 8, 66. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Sudarov, A.; Zhang, X.J.; Braunstein, L.; LoCastro, E.; Singh, S.; Taniguchi, Y.; Raj, A.; Shi, S.-H.; Moore, H.; Ross, M.E. Mature Hippocampal Neurons Require LIS1 for Synaptic Integrity: Implications for Cognition. Biol. Psychiatry 2018, 83, 518–529. [Google Scholar] [CrossRef] [PubMed]
  67. Wang, Y.; Baraban, S.C. Granule Cell Dispersion and Aberrant Neurogenesis in the Adult Hippocampus of an LIS1 Mutant Mouse. Dev. Neurosci. 2007, 29, 91–98. [Google Scholar] [CrossRef] [Green Version]
  68. Boyd, P.J.; Cunliffe, V.T.; Roy, S.; Wood, J.D. Sonic hedgehog functions upstream of disrupted-in-schizophrenia 1 (disc1): Implications for mental illness. Biol. Open 2015, 4, 1336–1343. [Google Scholar] [CrossRef] [Green Version]
  69. Araque, A.; Carmignoto, G.; Haydon, P.G.; Oliet, S.H.; Robitaille, R.; Volterra, A. Gliotransmitters Travel in Time and Space. Neuron 2014, 81, 728–739. [Google Scholar] [CrossRef] [Green Version]
  70. Bushong, E.A.; Martone, M.E.; Jones, Y.Z.; Ellisman, M.H. Protoplasmic Astrocytes in CA1 Stratum Radiatum Occupy Separate Anatomical Domains. J. Neurosci. 2002, 22, 183–192. [Google Scholar] [CrossRef]
  71. Bonni, A.; Sun, Y.; Nadal-Vicens, M.; Bhatt, A.; Frank, D.A.; Rozovsky, I.; Stahl, N.; Yancopoulos, G.D.; Greenberg, M.E. Regulation of Gliogenesis in the Central Nervous System by the JAK-STAT Signaling Pathway. Science 1997, 278, 477–483. [Google Scholar] [CrossRef]
  72. Ransom, B.; Behar, T.; Nedergaard, M. New roles for astrocytes (stars at last). Trends Neurosci. 2003, 26, 520–522. [Google Scholar] [CrossRef] [PubMed]
  73. Chiang, C.S.; Hong, J.H.; Stalder, A.; Sun, J.R.; Withers, H.R.; McBride, W.H. Delayed molecular responses to brain irradiation. Int. J. Radiat. Biol. 1997, 72, 45–53. [Google Scholar] [CrossRef]
  74. Hong, J.H.; Chiang, C.S.; Campbell, I.L.; Sun, J.R.; Withers, H.R.; McBride, W.H. Induction of acute phase gene expression by brain irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1995, 33, 619–626. [Google Scholar] [CrossRef]
  75. Hwang, S.Y.; Jung, J.S.; Kim, T.H.; Lim, S.J.; Oh, E.S.; Kim, J.Y.; Ji, K.A.; Joe, E.H.; Cho, K.H.; Han, I.O. Ionizing radiation induces astrocyte gliosis through microglia activation. Neurobiol. Dis. 2006, 21, 457–467. [Google Scholar] [CrossRef] [PubMed]
  76. Yuan, H.; Gaber, M.W.; Boyd, K.; Wilson, C.M.; Kiani, M.F.; Merchant, T.E. Effects of fractionated radiation on the brain vasculature in a murine model: Blood–brain barrier permeability, astrocyte proliferation, and ultrastructural changes. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66, 860–866. [Google Scholar] [CrossRef]
  77. Alvarez, J.I.; Dodelet-Devillers, A.; Kebir, H.; Ifergan, I.; Fabre, P.J.; Terouz, S.; Sabbagh, M.; Wosik, K.; Bourbonnière, L.; Bernard, M.; et al. The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence. Science 2011, 334, 1727–1731. [Google Scholar] [CrossRef] [Green Version]
  78. Garcia, A.D.R.; Han, Y.G.; Triplett, J.W.; Farmer, W.T.; Harwell, C.C.; Ihrie, R.A. The Elegance of Sonic Hedgehog: Emerging Novel Functions for a Classic Morphogen. J. Neurosci. 2018, 38, 9338–9345. [Google Scholar] [CrossRef]
  79. Hwang, S.N.; Lee, J.S.; Seo, K.; Lee, H. Astrocytic Regulation of Neural Circuits Underlying Behaviors. Cells 2021, 10, 296. [Google Scholar] [CrossRef]
  80. Oliveira, J.F.; Sardinha, V.M.; Guerra-Gomes, S.; Araque, A.; Sousa, N. Do stars govern our actions? Astrocyte involvement in rodent behavior. Trends Neurosci. 2015, 38, 535–549. [Google Scholar] [CrossRef] [Green Version]
  81. Woodbury, M.E.; Freilich, R.W.; Cheng, C.J.; Asai, H.; Ikezu, S.; Boucher, J.D.; Slack, F.; Ikezu, T. miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction. J. Neurosci. 2015, 35, 9764–9781. [Google Scholar] [CrossRef] [Green Version]
  82. Wu, M.D.; Hein, A.M.; Moravan, M.J.; Shaftel, S.S.; Olschowka, J.A.; O’Banion, M.K. Adult murine hippocampal neurogenesis is inhibited by sustained IL-1β and not rescued by voluntary running. Brain Behav. Immun. 2012, 26, 292–300. [Google Scholar] [CrossRef] [Green Version]
  83. Kirby, E.D.; Muroy, S.E.; Sun, W.G.; Covarrubias, D.; Leong, M.J.; Barchas, L.A.; Kaufer, D. Acute stress enhances adult rat hippocampal neurogenesis and activation of newborn neurons via secreted astrocytic FGF2. eLife 2013, 2, e00362. [Google Scholar] [CrossRef]
  84. Palmer, T.D.; Ray, J.; Gage, F.H. FGF-2-Responsive Neuronal Progenitors Reside in Proliferative and Quiescent Regions of the Adult Rodent Brain. Mol. Cell. Neurosci. 1995, 6, 474–486. [Google Scholar] [CrossRef] [PubMed]
  85. Galvez-Contreras, A.Y.; Gonzalez-Castaneda, R.E.; Luquin, S.; Gonzalez-Perez, O. Role of fibroblast growth factor receptors in astrocytic stem cells. Curr. Signal Transduct. Ther. 2012, 7, 81–86. [Google Scholar] [CrossRef] [Green Version]
  86. Zou, L.H.; Shi, Y.J.; He, H.; Jiang, S.M.; Huo, F.-F.; Wang, X.M.; Wu, F.; Ma, L. Effects of FGF2/FGFR1 Pathway on Expression of A1 Astrocytes After Infrasound Exposure. Front. Neurosci. 2019, 13, 429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  87. Lee, M.N.; Kim, J.W.; Oh, S.H.; Jeong, B.C.; Hwang, Y.C.; Koh, J.T. FGF2 Stimulates COUP-TFII Expression via the MEK1/2 Pathway to Inhibit Osteoblast Differentiation in C3H10T1/2 Cells. PLoS ONE 2016, 11, e0159234. [Google Scholar] [CrossRef] [Green Version]
  88. Krishnan, V.; Elberg, G.; Tsai, M.J.; Tsai, S.Y. Identification of a Novel Sonic Hedgehog Response Element in the Chicken Ovalbumin Upstream Promoter-Transcription Factor II Promoter. Mol. Endocrinol. 1997, 11, 1458–1466. [Google Scholar] [CrossRef] [PubMed]
  89. Zhang, K.; Yu, F.; Zhu, J.; Han, S.; Chen, J.; Wu, X.; Chen, Y.; Shen, T.; Liao, J.; Guo, W.; et al. Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation. Cell Rep. 2020, 31, 107521. [Google Scholar] [CrossRef]
  90. Bertacchi, M.; Gruart, A.; Kaimakis, P.; Allet, C.; Serra, L.; Giacobini, P.; Delgado-García, J.M.; Bovolenta, P.; Studer, M. Mouse Nr2f1 haploinsufficiency unveils new pathological mechanisms of a human optic atrophy syndrome. EMBO Mol. Med. 2019, 11, e10291. [Google Scholar] [CrossRef] [PubMed]
  91. Bonzano, S.; Crisci, I.; Podlesny-Drabiniok, A.; Rolando, C.; Krezel, W.; Studer, M.; De Marchis, S. Neuron-Astroglia Cell Fate Decision in the Adult Mouse Hippocampal Neurogenic Niche Is Cell-Intrinsically Controlled by COUP-TFI In Vivo. Cell Rep. 2018, 24, 329–341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Dutka, T.; Hallberg, D.; Reeves, R.H. Chronic up-regulation of the SHH pathway normalizes some developmental effects of trisomy in Ts65Dn mice. Mech. Dev. 2015, 135, 68–80. [Google Scholar] [CrossRef] [PubMed]
  93. Jackson, T.W.; Bendfeldt, G.A.; Beam, K.A.; Rock, K.D.; Belcher, S.M. Heterozygous mutation of sonic hedgehog receptor (Ptch1) drives cerebellar overgrowth and sex-specifically alters hippocampal and cortical layer structure, activity, and social behavior in female mice. Neurotoxicol. Teratol. 2020, 78, 106866. [Google Scholar] [CrossRef] [PubMed]
  94. Eriksson, P.; Ankarberg, E.; Fredriksson, A. Exposure to nicotine during a defined period in neonatal life induces permanent changes in brain nicotinic receptors and in behaviour of adult mice. Brain Res. 2000, 853, 41–48. [Google Scholar] [CrossRef]
  95. Chen, S.D.; Wu, C.L.; Hwang, W.C.; Yang, D.I. More Insight into BDNF against Neurodegeneration: Anti-Apoptosis, Anti-Oxidation, and Suppression of Autophagy. Int. J. Mol. Sci. 2017, 18, 545. [Google Scholar] [CrossRef] [Green Version]
  96. Huang, S.S.; Cheng, H.; Tang, C.M.; Nien, M.W.; Huang, Y.S.; Lee, I.H.; Yin, J.H.; Kuo, T.B.; Yang, C.C.; Tsai, S.K.; et al. Anti-oxidative, anti-apoptotic, and pro-angiogenic effects mediate functional improvement by sonic hedgehog against focal cerebral ischemia in rats. Exp. Neurol. 2013, 247, 680–688. [Google Scholar] [CrossRef]
  97. Suwelack, D.; Hurtado-Lorenzo, A.; Millan, E.; Gonzalez-Nicolini, V.; Wawrowsky, K.; Lowenstein, P.R.; Castro, M.G. Neuronal expression of the transcription factor Gli1 using the Tα1 α-tubulin promoter is neuroprotective in an experimental model of Parkinson’s disease. Gene Ther. 2004, 11, 1742–1752. [Google Scholar] [CrossRef] [Green Version]
  98. Wu, C.L.; Chen, S.D.; Hwang, C.S.; Yang, D.I. Sonic hedgehog mediates BDNF-induced neuroprotection against mitochondrial inhibitor 3-nitropropionic acid. Biochem. Biophys. Res. Commun. 2009, 385, 112–117. [Google Scholar] [CrossRef]
  99. Wu, C.L.; Chen, S.D.; Yin, J.H.; Hwang, C.S.; Yang, D.I. Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition. Neurobiol. Dis. 2010, 40, 146–154. [Google Scholar] [CrossRef]
  100. Jin, Y.; Raviv, N.; Barnett, A.; Bambakidis, N.C.; Filichia, E.; Luo, Y. The Shh Signaling Pathway Is Upregulated in Multiple Cell Types in Cortical Ischemia and Influences the Outcome of Stroke in an Animal Model. PLoS ONE 2015, 10, e0124657. [Google Scholar] [CrossRef]
  101. Jin, Y.; Barnett, A.; Zhang, Y.; Yu, X.; Luo, Y. Poststroke Sonic Hedgehog Agonist Treatment Improves Functional Recovery by Enhancing Neurogenesis and Angiogenesis. Stroke 2017, 48, 1636–1645. [Google Scholar] [CrossRef]
  102. Chechneva, O.V.; Mayrhofer, F.; Daugherty, D.J.; Krishnamurty, R.G.; Bannerman, P.; Pleasure, D.E.; Deng, W. A Smoothened receptor agonist is neuroprotective and promotes regeneration after ischemic brain injury. Cell Death Dis. 2014, 5, e1481. [Google Scholar] [CrossRef] [Green Version]
  103. Das, I.; Park, J.M.; Shin, J.H.; Jeon, S.K.; Lorenzi, H.; Linden, D.J.; Worley, P.F.; Reeves, R.H. Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model. Sci. Transl. Med. 2013, 5, 201ra120. [Google Scholar] [CrossRef] [Green Version]
  104. He, P.; Staufenbiel, M.; Li, R.; Shen, Y. Deficiency of Patched 1-induced Gli1 signal transduction results in astrogenesis in Swedish mutated APP transgenic mice. Hum. Mol. Genet. 2014, 23, 6512–6527. [Google Scholar] [CrossRef] [Green Version]
  105. Eriksson, P.; Ankarberg, E.; Viberg, H.; Fredriksson, A. The developing cholinergic system as target for environmental toxicants, nicotine and polychlorinated biphenyls (PCBs): Implications for neurotoxicological processes in mice. Neurotox. Res. 2001, 3, 37–51. [Google Scholar] [CrossRef] [PubMed]
  106. Casciati, A.; Dobos, K.; Antonelli, F.; Benedek, A.; Kempf, S.J.; Belles, M.; Balogh, A.; Tanori, M.; Heredia, L.; Atkinson, M.J.; et al. Age-related effects of X-ray irradiation on mouse hippocampus. Oncotarget 2016, 7, 28040–28058. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Hagihara, H.; Toyama, K.; Yamasaki, N.; Miyakawa, T. Dissection of Hippocampal Dentate Gyrus from Adult Mouse. J. Vis. Exp. 2009, 33, e1543–e1549. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  108. Bellés, M.; Alonso, V.; Linares, V.; Albina, M.L.; Sirvent, J.J.; Domingo, J.L.; Sánchez, D.J. Behavioral effects and oxidative status in brain regions of adult rats exposed to BDE-99. Toxicol. Lett. 2010, 194, 1–7. [Google Scholar] [CrossRef] [PubMed]
  109. Vicens, P.; Ribes, D.; Torrente, M.; Domingo, J.L. Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice. Behav. Brain Res. 2011, 216, 341–348. [Google Scholar] [CrossRef]
  110. Heredia, L.; Bellés, M.; Llovet, M.I.; Domingo, J.L.; Linares, V. Neurobehavioral effects of concurrent exposure to cesium-137 and paraquat during neonatal development in mice. Toxicology 2015, 329, 73–79. [Google Scholar] [CrossRef]
  111. Lalonde, R.; Strazielle, C. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6JIco and BALB/cAnN@Ico mice injected with ethanol. Fundam. Clin. Pharmacol. 2012, 26, 271–278. [Google Scholar] [CrossRef] [PubMed]
  112. Heredia, L.; Bellés, M.; Llovet, M.I.; Domingo, J.L.; Linares, V. Behavioral effects in mice of postnatal exposure to low-doses of 137-cesium and bisphenol A. Toxicology 2016, 340, 10–16. [Google Scholar] [CrossRef] [PubMed]
  113. Walf, A.A.; Frye, C.A. Estradiol decreases anxiety behavior and enhances inhibitory avoidance and gestational stress produces opposite effects. Stress 2007, 10, 251–260. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Effect of irradiation with 5 Gy of X-rays at P10 on the lineage-specific composition of DG in WT and Ptch1+/− mice at 2 or 8 months post-irradiation. (A) Schematic representation of adult neurogenesis in the hippocampal DG and relative stage-specific markers. Representative immunostaining images and quantification for (B) glial fibrillary acidic protein (GFAP), (C) sex determining region Y (SRY) box 2 (SOX2), (D) doublecortin (DCX) and (E) mature neurons (NeuN). The red rectangular field of 2000 µm2 in E delineates a representative area in which NeuN analysis was carried out. Images, 100× magnification, scale bar = 10 µm. Immunohistochemical analysis for NeuN was carried out in a rectangular field of 2000 µm2 in the supra- and infrapyramidal blade. The number of mice used per test is indicated with n in the graphs (n). Data are reported as mean ± SEM * p < 0.05; ** p < 0.01; *** p < 0.001 for comparison with controls (Student t-test).
Figure 1. Effect of irradiation with 5 Gy of X-rays at P10 on the lineage-specific composition of DG in WT and Ptch1+/− mice at 2 or 8 months post-irradiation. (A) Schematic representation of adult neurogenesis in the hippocampal DG and relative stage-specific markers. Representative immunostaining images and quantification for (B) glial fibrillary acidic protein (GFAP), (C) sex determining region Y (SRY) box 2 (SOX2), (D) doublecortin (DCX) and (E) mature neurons (NeuN). The red rectangular field of 2000 µm2 in E delineates a representative area in which NeuN analysis was carried out. Images, 100× magnification, scale bar = 10 µm. Immunohistochemical analysis for NeuN was carried out in a rectangular field of 2000 µm2 in the supra- and infrapyramidal blade. The number of mice used per test is indicated with n in the graphs (n). Data are reported as mean ± SEM * p < 0.05; ** p < 0.01; *** p < 0.001 for comparison with controls (Student t-test).
Ijms 22 12605 g001
Figure 2. Long-term effect of irradiation with 5 Gy of X-rays at P10 in astrocytes in WT and Ptch1+/− mice at 2 or 8 months post-irradiation. (A) Representative immunostaining image of GFAP+ astrocytes in the molecular layer (ML) of the hippocampus. (B) Astrocyte quantification in unirradiated and irradiated WT and Ptch1+/− mice. Image, 100× magnification, scale bar = 10 µm. The number of mice used per test is indicated with n in the graphs. Data are reported as mean ± SEM * p < 0.05; ** p < 0.01; *** p < 0.001 for comparison with controls (Student t-test).
Figure 2. Long-term effect of irradiation with 5 Gy of X-rays at P10 in astrocytes in WT and Ptch1+/− mice at 2 or 8 months post-irradiation. (A) Representative immunostaining image of GFAP+ astrocytes in the molecular layer (ML) of the hippocampus. (B) Astrocyte quantification in unirradiated and irradiated WT and Ptch1+/− mice. Image, 100× magnification, scale bar = 10 µm. The number of mice used per test is indicated with n in the graphs. Data are reported as mean ± SEM * p < 0.05; ** p < 0.01; *** p < 0.001 for comparison with controls (Student t-test).
Ijms 22 12605 g002
Figure 3. Long-term effect of irradiation with 5 Gy of X-rays at P10 on the expression of neurogenesis-related genes in the hippocampus of WT and Ptch1+/− mice at 8 months post-irradiation. Venn diagram of the exclusively deregulated and shared genes in the hippocampus of WT and Ptch1+/− mice irradiated vs. their respective unirradiated counterparts. A p-value ≤ 0.05 and a fold-regulation > 2 was defined as upregulation (blue); a p-value ≤0.05 and fold-regulation of <2 as downregulation (red).
Figure 3. Long-term effect of irradiation with 5 Gy of X-rays at P10 on the expression of neurogenesis-related genes in the hippocampus of WT and Ptch1+/− mice at 8 months post-irradiation. Venn diagram of the exclusively deregulated and shared genes in the hippocampus of WT and Ptch1+/− mice irradiated vs. their respective unirradiated counterparts. A p-value ≤ 0.05 and a fold-regulation > 2 was defined as upregulation (blue); a p-value ≤0.05 and fold-regulation of <2 as downregulation (red).
Ijms 22 12605 g003
Figure 4. Long-term behavioral effect of irradiation with 5 Gy of X-rays at P10 in WT and Ptch1+/ mice at 8 months post-irradiation assessed through Open Field (OF) and Elevated Plus-Maze (EPM) tests. WT (n = 18) and Ptch1+/− (n = 15) mice irradiated or left unirradiated (n = 17 for WT; n = 12 for Ptch1+/−) were submitted to the tests. (A) Number of rearings in OF; (B) Total distance travelled in OF; (C) Total distance travelled (habituation) in OF. (D) Total distance travelled in EPM; (E) Time in open arms in EPM; (F) Number of entries into the open arms in EPM; (G) Number of head dips in EPM. Data are given as the mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001. Statistical significance for all tests (described in the “Cognitive Statistical Analysis” paragraph) was established at p < 0.05.
Figure 4. Long-term behavioral effect of irradiation with 5 Gy of X-rays at P10 in WT and Ptch1+/ mice at 8 months post-irradiation assessed through Open Field (OF) and Elevated Plus-Maze (EPM) tests. WT (n = 18) and Ptch1+/− (n = 15) mice irradiated or left unirradiated (n = 17 for WT; n = 12 for Ptch1+/−) were submitted to the tests. (A) Number of rearings in OF; (B) Total distance travelled in OF; (C) Total distance travelled (habituation) in OF. (D) Total distance travelled in EPM; (E) Time in open arms in EPM; (F) Number of entries into the open arms in EPM; (G) Number of head dips in EPM. Data are given as the mean ± SEM. * p < 0.05; ** p < 0.01; *** p < 0.001. Statistical significance for all tests (described in the “Cognitive Statistical Analysis” paragraph) was established at p < 0.05.
Ijms 22 12605 g004
Figure 5. Schematic summary of long-term radiation-induced effects in the hippocampus of WT and Ptch1+/− mice. In WT mice, irradiation with 5 Gy of X-rays at P10 induces neurogenesis deficit and astrogliosis, associated with deregulation of genes involved in the injury response (A2AR and ep300 upregulated; Alk and Cxcl1, downregulated). In Ptch1+/− mice we detected a protective role of constitutive Shh pathway activation on neurogenesis deficits and astrogliosis, that was associated with the deregulation of a large number of proneural genes and possibly with a switch from astroglia toward a neuronal cell fate that might contribute to the restoration of neurogenesis.
Figure 5. Schematic summary of long-term radiation-induced effects in the hippocampus of WT and Ptch1+/− mice. In WT mice, irradiation with 5 Gy of X-rays at P10 induces neurogenesis deficit and astrogliosis, associated with deregulation of genes involved in the injury response (A2AR and ep300 upregulated; Alk and Cxcl1, downregulated). In Ptch1+/− mice we detected a protective role of constitutive Shh pathway activation on neurogenesis deficits and astrogliosis, that was associated with the deregulation of a large number of proneural genes and possibly with a switch from astroglia toward a neuronal cell fate that might contribute to the restoration of neurogenesis.
Ijms 22 12605 g005
Table 1. Significantly deregulated genes in irradiated mice (WT or Ptch1+/− mice) vs. unirradiated CN (WT or Ptch1+/− mice) 8 months after irradiation. Upregulated genes (black); downregulated genes (red).
Table 1. Significantly deregulated genes in irradiated mice (WT or Ptch1+/− mice) vs. unirradiated CN (WT or Ptch1+/− mice) 8 months after irradiation. Upregulated genes (black); downregulated genes (red).
Synaptic FunctionsCell DifferentiationApoptosisGrowth FactorsCell Adhesion/Neural MigrationCell Cycle/Transcription FactorsSignal Transduction
WTErbb2Pax6Adora2a
Ep300
Alk
Cxcl1Slit2Ep300Adora2a
Cxcl1
Ptch1+/-Chrm2
Fgf2
Pafah1b1
S100b
Apbb1
ApoE
Nrg1
Pafah1b1
Pax5
S100b
ApoE
Fgf2
Nrg1
Ptn
Pafah1b1
Rac1
Robo1
Ptn
Flna
Nrg1
Dll1
WT
Ptch1+/-
App
Bdnf
Creb1
Dcx
Drd2
Map2
Notch1
Bdnf
Mdk
NeuroD1
Ntf3
Olig2
Sox2
Notch2Artn
Mdk
Ndp
Dcx
Drd2
MdkApp
Notch1
Notch2
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Antonelli, F.; Casciati, A.; Belles, M.; Serra, N.; Linares-Vidal, M.V.; Marino, C.; Mancuso, M.; Pazzaglia, S. Long-Term Effects of Ionizing Radiation on the Hippocampus: Linking Effects of the Sonic Hedgehog Pathway Activation with Radiation Response. Int. J. Mol. Sci. 2021, 22, 12605. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212605

AMA Style

Antonelli F, Casciati A, Belles M, Serra N, Linares-Vidal MV, Marino C, Mancuso M, Pazzaglia S. Long-Term Effects of Ionizing Radiation on the Hippocampus: Linking Effects of the Sonic Hedgehog Pathway Activation with Radiation Response. International Journal of Molecular Sciences. 2021; 22(22):12605. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212605

Chicago/Turabian Style

Antonelli, Francesca, Arianna Casciati, Montserrat Belles, Noemi Serra, Maria Victoria Linares-Vidal, Carmela Marino, Mariateresa Mancuso, and Simonetta Pazzaglia. 2021. "Long-Term Effects of Ionizing Radiation on the Hippocampus: Linking Effects of the Sonic Hedgehog Pathway Activation with Radiation Response" International Journal of Molecular Sciences 22, no. 22: 12605. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms222212605

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop